Vaxcyte CEO Grant Pickering Surrenders 17,056 Shares for Taxes

What Happened

• Grant Pickering, CEO of Vaxcyte (PCVX), surrendered 17,056 shares on Sept 8, 2026 to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs). The shares were valued at $60.36 each, totaling approximately $1,029,500. This was a share surrender for tax withholding (transaction code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-09-08; filing date: 2026-09-09 (appears timely under Form 4 rules).
• Price per share: $60.36; total value surrendered: ~$1,029,500.
• Transaction type: F — shares surrendered to issuer to cover tax withholding on vesting (cashless/share-withholding settlement).
• Shares owned after the transaction: not specified in the provided filing data.
• Relevant footnotes: F1 confirms shares were surrendered to cover tax withholding on vested RSUs; F2 and F3 note certain shares are held in trusts for the reporting person’s son and daughter.

Context

• This was a routine tax-withholding share surrender related to RSU vesting, not a directional buy or open-market sale. Such transactions are common and generally reflect tax settlement mechanics rather than a statement about the insider’s view of the company.